BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
View all
Fund detail sections
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q2 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Month-End Total Returns as of 4/30/2024
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -12.32% | -11.60% | 21.54% | -11.51% | -9.06% | -17.02% | 0.30% | 3.09% | 14.54% | 04/07/2010 |
| BIB NAV | -12.42% | -11.61% | 21.43% | -11.70% | -9.07% | -16.99% | 0.24% | 3.07% | 14.53% | 04/07/2010 |
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
| BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/15/2024- NAV $57.58
- NAV Change $+1.30
- Market Price $57.53
- Market Price Change $+1.21
- Trading Volume (M) 55,811
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/15/2024- NAV $57.58
- NAV Change $+1.30
- Market Price $57.53
- Market Price Change $+1.21
- Trading Volume (M) 55,811
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 5/15/2024
| Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
|---|---|---|---|---|---|---|
| 46.05% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 42,446,618 | -- | 9,526 | -- |
| 35.89% | -- | NASDAQ BIO INDEX SWAP BNP | 33,084,835 | -- | 7,425 | -- |
| 18.82% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 17,346,702 | -- | 3,893 | -- |
| 14.64% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 13,496,830 | -- | 3,029 | -- |
| 6.47% | AMGN | AMGEN INC | -- | $5,960,305.28 | 18,682 | 2023607 |
| 6.39% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,886,204 | -- | 1,321 | -- |
| 5.81% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 5,355,956 | -- | 1,202 | -- |
| 5.77% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $5,319,440.91 | 12,159 | 2931034 |
| 5.62% | REGN | REGENERON PHARMACEUTICALS | -- | $5,180,600.16 | 5,296 | 2730190 |
| 5.16% | GILD | GILEAD SCIENCES INC | -- | $4,754,292.49 | 70,949 | 2369174 |
| 3.49% | MRNA | MODERNA INC | -- | $3,220,434.18 | 24,953 | BGSXTS3 |
| 3.30% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,043,359 | -- | 683 | -- |
| 3.18% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,926,861.22 | 38,026 | 2989044 |
| 2.42% | BIIB | BIOGEN INC | -- | $2,233,657.44 | 9,492 | 2455965 |
| 1.32% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,212,512.40 | 8,226 | B00FWN1 |
| 1.29% | ILMN | ILLUMINA INC | -- | $1,193,228.75 | 10,375 | 2613990 |
| 1.07% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $990,367.20 | 12,318 | 2437071 |
| 1.00% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $923,142.00 | 6,501 | 2623911 |
| 0.95% | SNY | SANOFI-ADR | -- | $876,739.89 | 17,889 | 2964557 |
| 0.93% | VTRS | VIATRIS INC | -- | $858,489.57 | 77,551 | BMWS3X9 |
| 0.91% | UTHR | UNITED THERAPEUTICS CORP | -- | $838,521.75 | 3,075 | 2430412 |
| 0.91% | INCY | INCYTE CORP | -- | $836,638.25 | 14,665 | 2471950 |
| 0.89% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $822,942.12 | 29,172 | BMVP7Y0 |
| 0.89% | MEDP | MEDPACE HOLDINGS INC | -- | $815,818.80 | 2,010 | BDCBC61 |
| 0.88% | SRPT | SAREPTA THERAPEUTICS INC | -- | $812,225.00 | 6,130 | B8DPDT7 |
| 0.83% | ARGX | ARGENX SE - ADR | -- | $765,605.76 | 2,031 | BDVLM39 |
| 0.66% | ROIV | ROIVANT SCIENCES LTD | -- | $605,176.00 | 52,624 | BMW4NZ9 |
| 0.63% | BNTX | BIONTECH SE-ADR | -- | $582,796.20 | 6,321 | BK6H543 |
| 0.55% | PCVX | VAXCYTE INC | -- | $506,925.51 | 7,077 | BKPVGH6 |
| 0.50% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $465,398.08 | 3,752 | BV9G6B8 |
| 0.48% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $446,641.80 | 4,070 | B4Q5ZN4 |
| 0.48% | BGNE | BEIGENE LTD-ADR | -- | $445,835.52 | 2,704 | BYYWPW6 |
| 0.46% | BPMC | BLUEPRINT MEDICINES CORP | -- | $427,160.00 | 4,000 | BWY52P3 |
| 0.46% | RVMD | REVOLUTION MEDICINES INC | -- | $423,718.23 | 10,757 | BL71K91 |
| 0.46% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $422,763.00 | 6,325 | BHCB0P4 |
| 0.45% | EXEL | EXELIXIS INC | -- | $418,218.24 | 19,802 | 2576941 |
| 0.44% | CYTK | CYTOKINETICS INC | -- | $406,741.50 | 6,723 | BBBSBJ5 |
| 0.41% | HALO | HALOZYME THERAPEUTICS INC | -- | $379,389.60 | 8,280 | 2975098 |
| 0.40% | IONS | IONIS PHARMACEUTICALS INC | -- | $373,318.41 | 9,521 | BDJ0LS6 |
| 0.38% | IBRX | IMMUNITYBIO INC | -- | $353,176.20 | 43,602 | BNSP0B8 |
| 0.37% | BBIO | BRIDGEBIO PHARMA INC | -- | $344,085.57 | 11,481 | BK1KWG8 |
| 0.36% | APLS | APELLIS PHARMACEUTICALS INC | -- | $330,245.76 | 7,878 | BYTQ6X1 |
| 0.33% | KRYS | KRYSTAL BIOTECH INC | -- | $301,085.55 | 1,845 | BD6JX35 |
| 0.32% | CRSP | CRISPR THERAPEUTICS AG | -- | $298,641.28 | 5,243 | BDHF4K6 |
| 0.32% | IMVT | IMMUNOVANT INC | -- | $293,432.91 | 9,487 | BJRFSB7 |
| 0.30% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $278,201.54 | 4,282 | BYX38M1 |
| 0.30% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $275,460.73 | 1,301 | BD59BS7 |
| 0.30% | NUVL | NUVALENT INC-A | -- | $274,606.08 | 3,831 | BMVBZD3 |
| 0.29% | ALKS | ALKERMES PLC | -- | $263,367.40 | 10,910 | B3P6D26 |
| 0.26% | INSM | INSMED INC | -- | $241,696.35 | 9,695 | 2614487 |
| 0.26% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $238,180.80 | 5,205 | BMX9K07 |
| 0.25% | AXSM | AXSOME THERAPEUTICS INC | -- | $234,775.56 | 3,092 | BYZR4X4 |
| 0.25% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $229,578.03 | 4,547 | BDD19F8 |
| 0.24% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $221,143.36 | 5,378 | BJ62Z18 |
| 0.24% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $217,683.20 | 4,816 | BGMGM89 |
| 0.22% | IDYA | IDEAYA BIOSCIENCES INC | -- | $206,555.48 | 4,867 | BK0VHF6 |
| 0.22% | SMMT | SUMMIT THERAPEUTICS INC | -- | $205,740.78 | 45,822 | BMTVQS7 |
| 0.22% | GH | GUARDANT HEALTH INC | -- | $204,686.75 | 7,949 | BFXC911 |
| 0.22% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $202,648.72 | 8,093 | BYQBFJ8 |
| 0.22% | XENE | XENON PHARMACEUTICALS INC | -- | $199,256.70 | 4,926 | BRJ3GY4 |
| 0.21% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $194,803.20 | 18,240 | BF0DMK7 |
| 0.21% | DNLI | DENALI THERAPEUTICS INC | -- | $189,554.82 | 9,087 | BD2B4V0 |
| 0.20% | FOLD | AMICUS THERAPEUTICS INC | -- | $186,331.74 | 19,289 | B19FQ48 |
| 0.20% | TWST | TWIST BIOSCIENCE CORP | -- | $182,607.36 | 3,776 | BGKG6G7 |
| 0.19% | ACLX | ARCELLX INC | -- | $178,227.12 | 3,446 | BPCJ1Q2 |
| 0.19% | MRUS | MERUS NV | -- | $170,939.01 | 3,781 | BZBY005 |
| 0.18% | PTCT | PTC THERAPEUTICS INC | -- | $168,367.32 | 5,002 | B17VCN9 |
| 0.18% | FTRE | FORTREA HOLDINGS INC | -- | $166,750.92 | 5,796 | BRXYZ57 |
| 0.18% | NTLA | INTELLIA THERAPEUTICS INC | -- | $164,609.16 | 6,278 | BYZM6C2 |
| 0.18% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $162,751.68 | 10,764 | 2713317 |
| 0.17% | JANX | JANUX THERAPEUTICS INC | -- | $157,063.84 | 3,308 | BMFX8Y7 |
| 0.17% | VCEL | VERICEL CORP | -- | $155,789.73 | 3,153 | BSBMN89 |
| 0.17% | DYN | DYNE THERAPEUTICS INC | -- | $155,655.24 | 5,298 | BN15WD1 |
| 0.17% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $155,430.00 | 3,925 | BF2YWG4 |
| 0.17% | RNA | AVIDITY BIOSCIENCES INC | -- | $153,688.08 | 5,208 | BMWHPY1 |
| 0.16% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $148,498.35 | 14,835 | BM9FJ13 |
| 0.16% | NVCR | NOVOCURE LTD | -- | $147,160.55 | 6,991 | BYSS4X4 |
| 0.16% | VERA | VERA THERAPEUTICS INC | -- | $146,426.70 | 3,430 | BL55460 |
| 0.16% | MYGN | MYRIAD GENETICS INC | -- | $144,778.86 | 5,871 | 2614153 |
| 0.16% | ARVN | ARVINAS INC | -- | $143,771.51 | 4,447 | BDZ30Q0 |
| 0.16% | KYMR | KYMERA THERAPEUTICS INC | -- | $143,436.54 | 3,991 | BMPRZV5 |
| 0.15% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $139,854.26 | 5,911 | BDFKQ07 |
| 0.15% | GERN | GERON CORP | -- | $139,066.20 | 35,658 | 2370381 |
| 0.15% | ADMA | ADMA BIOLOGICS INC | -- | $135,617.30 | 14,903 | B9NSBM2 |
| 0.15% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $134,274.20 | 5,276 | BZ1LFB2 |
| 0.14% | SANA | SANA BIOTECHNOLOGY INC | -- | $133,478.73 | 14,399 | BMFJJ97 |
| 0.14% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $133,261.60 | 3,140 | BNFWZS4 |
| 0.14% | APGE | APOGEE THERAPEUTICS INC | -- | $129,359.10 | 2,427 | BM9HHL5 |
| 0.14% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $129,005.06 | 3,667 | BCBVTX1 |
| 0.14% | BEAM | BEAM THERAPEUTICS INC | -- | $128,578.63 | 5,333 | BK6L288 |
| 0.14% | KROS | KEROS THERAPEUTICS INC | -- | $127,840.00 | 2,350 | BM7V485 |
| 0.14% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $126,078.51 | 2,251 | BLCD809 |
| 0.13% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $121,745.06 | 5,549 | BN7Q7R7 |
| 0.13% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $119,711.88 | 3,804 | BDCBCD8 |
| 0.13% | ARDX | ARDELYX INC | -- | $119,304.30 | 15,198 | BN89V40 |
| 0.13% | NVAX | NOVAVAX INC | -- | $117,906.00 | 9,140 | BJDQXG4 |
| 0.13% | VCYT | VERACYTE INC | -- | $115,512.75 | 4,905 | BFTWZY0 |
| 0.12% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $114,666.53 | 3,179 | BQS9486 |
| 0.12% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $110,008.80 | 3,704 | BKSGZN7 |
| 0.12% | KURA | KURA ONCOLOGY INC | -- | $108,737.64 | 4,972 | BYZD465 |
| 0.12% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $107,494.40 | 6,080 | BKY5JZ8 |
| 0.12% | INBX | INHIBRX INC | -- | $106,306.41 | 3,093 | BK1MBC3 |
| 0.11% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $102,630.54 | 3,571 | B72ZBG4 |
| 0.11% | FUSN | FUSION PHARMACEUTICALS INC | -- | $101,776.50 | 4,725 | BJK0NH0 |
| 0.11% | LGND | LIGAND PHARMACEUTICALS | -- | $99,150.12 | 1,156 | 2501578 |
| 0.11% | MORF | MORPHIC HOLDING INC | -- | $98,731.18 | 3,266 | BK8M4J4 |
| 0.10% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $96,745.60 | 8,638 | BMCWKZ2 |
| 0.10% | -- | AVADEL PHARMACEUTICALS | -- | $94,303.49 | 5,861 | BDGMC59 |
| 0.10% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $94,182.24 | 8,531 | BRJZSK0 |
| 0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $93,659.68 | 5,704 | BLB0YH0 |
| 0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $91,413.12 | 3,039 | B3X26D8 |
| 0.10% | ANIP | ANI PHARMACEUTICALS INC | -- | $89,127.50 | 1,375 | BCDWBX6 |
| 0.10% | VIR | VIR BIOTECHNOLOGY INC | -- | $88,346.34 | 8,817 | BK4PZ38 |
| 0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $86,124.50 | 2,237 | BMH5RL1 |
| 0.09% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $85,643.76 | 13,466 | 2100362 |
| 0.09% | XNCR | XENCOR INC | -- | $84,968.39 | 3,991 | BGCYWN8 |
| 0.09% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $83,186.16 | 3,252 | BKLXFX5 |
| 0.09% | GMAB | GENMAB A/S -SP ADR | -- | $82,712.14 | 2,737 | BBC9WC7 |
| 0.09% | MNKD | MANNKIND CORP | -- | $78,591.45 | 17,661 | BF081J4 |
| 0.09% | PRTA | PROTHENA CORP PLC | -- | $78,566.51 | 3,509 | B91XRN2 |
| 0.08% | AKRO | AKERO THERAPEUTICS INC | -- | $77,453.32 | 3,676 | BK7Y2V9 |
| 0.08% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $76,044.57 | 3,043 | BJDX8Y8 |
| 0.08% | CGEM | CULLINAN THERAPEUTICS INC | -- | $74,655.68 | 2,794 | BM90J52 |
| 0.08% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $70,916.26 | 2,087 | BX7RSN3 |
| 0.08% | ABCL | ABCELLERA BIOLOGICS INC | -- | $70,744.00 | 19,120 | BL53SR3 |
| 0.07% | ZLAB | ZAI LAB LTD-ADR | -- | $67,428.90 | 3,234 | BD9GVY0 |
| 0.07% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $67,076.00 | 10,225 | B3MZ6K5 |
| 0.07% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $66,156.48 | 4,712 | BFZQ0L8 |
| 0.07% | INVA | INNOVIVA INC | -- | $65,403.36 | 4,129 | BDDXF67 |
| 0.07% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $64,536.00 | 2,689 | BMFD115 |
| 0.07% | VRNA | VERONA PHARMA PLC - ADR | -- | $61,910.10 | 4,438 | BYWPZK5 |
| 0.07% | GRFS | GRIFOLS SA-ADR | -- | $61,250.85 | 7,965 | B8K7T65 |
| 0.07% | PLRX | PLIANT THERAPEUTICS INC | -- | $60,395.52 | 3,932 | BMDWW66 |
| 0.06% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $58,452.24 | 6,326 | BKX9VD3 |
| 0.06% | RLAY | RELAY THERAPEUTICS INC | -- | $58,219.56 | 8,568 | BN2R582 |
| 0.06% | ETNB | 89BIO INC | -- | $56,009.60 | 6,088 | BK1K484 |
| 0.06% | SPRY | ARS PHARMACEUTICALS INC | -- | $55,686.48 | 6,271 | BMCR7V2 |
| 0.06% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $55,516.10 | 4,636 | BMQ5T49 |
| 0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $52,461.00 | 2,610 | BD0MGM0 |
| 0.06% | COGT | COGENT BIOSCIENCES INC | -- | $52,387.92 | 6,786 | BLR6XK8 |
| 0.06% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $52,054.08 | 2,328 | BKDQKM6 |
| 0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $51,963.60 | 6,662 | BP2P6L0 |
| 0.06% | PRME | PRIME MEDICINE INC | -- | $51,463.88 | 7,613 | BPBJFM7 |
| 0.06% | NRIX | NURIX THERAPEUTICS INC | -- | $50,752.80 | 3,192 | BMVLGP2 |
| 0.06% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $50,718.22 | 1,748 | BKC9SX3 |
| 0.05% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $50,147.64 | 9,444 | BFWLC09 |
| 0.05% | IRON | DISC MEDICINE INC | -- | $50,115.78 | 1,573 | BMGJZJ8 |
| 0.05% | EOLS | EVOLUS INC | -- | $49,424.92 | 3,733 | BDRJH21 |
| 0.05% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $48,890.10 | 3,255 | BLN7XQ1 |
| 0.05% | RGNX | REGENXBIO INC | -- | $47,131.92 | 2,904 | BZ0G875 |
| 0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $47,017.10 | 7,969 | BYZG9R0 |
| 0.05% | CVAC | CUREVAC NV | -- | $46,640.99 | 14,621 | BN4RD42 |
| 0.05% | SAGE | SAGE THERAPEUTICS INC | -- | $46,008.59 | 3,929 | BP4GNK9 |
| 0.05% | OCUL | OCULAR THERAPEUTIX INC | -- | $45,288.00 | 7,200 | BNZB1X8 |
| 0.05% | ANAB | ANAPTYSBIO INC | -- | $44,467.20 | 1,737 | BDRW1L7 |
| 0.05% | HUMA | HUMACYTE INC | -- | $43,788.96 | 6,768 | BMYTJP4 |
| 0.05% | CSTL | CASTLE BIOSCIENCES INC | -- | $43,726.20 | 1,795 | BKLCWZ3 |
| 0.05% | HCM | HUTCHMED CHINA-ADR | -- | $43,595.65 | 2,023 | BYXV9H7 |
| 0.05% | LYEL | LYELL IMMUNOPHARMA INC | -- | $43,310.34 | 16,594 | BN6MB18 |
| 0.05% | SVRA | SAVARA INC | -- | $42,697.20 | 8,840 | BYXGN81 |
| 0.05% | ITOS | ITEOS THERAPEUTICS INC | -- | $41,936.60 | 2,335 | BMWXFT4 |
| 0.05% | ZYME | ZYMEWORKS INC | -- | $41,833.80 | 4,572 | BPCQZY9 |
| 0.04% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $41,252.72 | 3,188 | BMGS7L1 |
| 0.04% | ORIC | ORIC PHARMACEUTICALS INC | -- | $40,964.00 | 4,400 | BKVDFF7 |
| 0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $38,943.81 | 3,741 | BJLKVS6 |
| 0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $37,979.32 | 12,212 | BNC1BX1 |
| 0.04% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $37,539.65 | 17,501 | B4N8MH9 |
| 0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $37,484.12 | 1,289 | B292NQ7 |
| 0.04% | PETQ | PETIQ INC | -- | $37,376.66 | 1,906 | BDH65C8 |
| 0.04% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $36,944.70 | 9,473 | BJ5FZ74 |
| 0.04% | HROW | HARROW INC | -- | $36,500.10 | 2,292 | BHNDW86 |
| 0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $36,199.80 | 4,641 | 2107437 |
| 0.04% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $36,132.42 | 9,194 | BFMLGR4 |
| 0.04% | CABA | CABALETTA BIO INC | -- | $35,519.31 | 2,799 | BK5MWR1 |
| 0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $35,450.15 | 3,599 | BMZ4LN0 |
| 0.04% | ALEC | ALECTOR INC | -- | $35,335.10 | 6,254 | BJ4LDC4 |
| 0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $35,119.09 | 2,687 | BP9N0G0 |
| 0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $34,859.16 | 2,862 | BG31GH0 |
| 0.04% | OABI | OMNIAB INC | -- | $34,467.68 | 7,592 | BN13S71 |
| 0.04% | THRD | THIRD HARMONIC BIO INC | -- | $34,082.96 | 2,638 | BNNPQY8 |
| 0.04% | VERV | VERVE THERAPEUTICS INC | -- | $34,028.26 | 5,462 | BNKGXX2 |
| 0.04% | TVTX | TRAVERE THERAPEUTICS INC | -- | $33,796.00 | 4,970 | BLFGJD5 |
| 0.04% | FULC | FULCRUM THERAPEUTICS INC | -- | $33,379.50 | 4,046 | BJDX8Z9 |
| 0.04% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $32,744.24 | 10,988 | BFZNYB7 |
| 0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $32,631.17 | 2,717 | BD06CS0 |
| 0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $32,364.78 | 3,682 | BLB0YQ9 |
| 0.04% | MXCT | MAXCYTE INC | -- | $32,283.36 | 6,768 | BKMQF66 |
| 0.03% | EDIT | EDITAS MEDICINE INC | -- | $32,076.00 | 5,346 | BZ8FPH3 |
| 0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $32,051.90 | 3,254 | BMNDK09 |
| 0.03% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $30,919.72 | 15,938 | BWFZX59 |
| 0.03% | BMEA | BIOMEA FUSION INC | -- | $30,835.96 | 2,329 | BNKF6N0 |
| 0.03% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $30,775.12 | 10,952 | BZ0QMB7 |
| 0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $30,389.22 | 3,546 | BY7RB53 |
| 0.03% | SLRN | ACELYRIN INC | -- | $30,136.92 | 6,358 | BQPF874 |
| 0.03% | URGN | UROGEN PHARMA LTD | -- | $27,808.04 | 2,018 | BZ7PJQ1 |
| 0.03% | REPL | REPLIMUNE GROUP INC | -- | $27,321.72 | 4,012 | BDDVW37 |
| 0.03% | TRML | TOURMALINE BIO INC | -- | $25,513.25 | 1,673 | BQ80NC6 |
| 0.03% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $24,217.75 | 1,327 | BL95N25 |
| 0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $24,169.65 | 4,035 | BMDJ0C9 |
| 0.03% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $24,075.38 | 5,362 | BYTYP72 |
| 0.03% | AMRN | AMARIN CORP PLC -ADR | -- | $23,582.81 | 25,198 | 2301938 |
| 0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $23,447.90 | 8,170 | BNG1NK8 |
| 0.03% | PGEN | PRECIGEN INC | -- | $23,411.52 | 16,258 | BKM5C84 |
| 0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $22,960.56 | 4,152 | BFYQFJ2 |
| 0.02% | ACIU | AC IMMUNE SA | -- | $22,657.05 | 6,455 | BZC0D70 |
| 0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $22,230.20 | 10,844 | BN6M8F1 |
| 0.02% | CRBU | CARIBOU BIOSCIENCES INC | -- | $21,028.28 | 5,777 | BNYJR68 |
| 0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $20,393.87 | 5,497 | BLN9Z50 |
| 0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $20,132.16 | 3,756 | B12W3P6 |
| 0.02% | MGNX | MACROGENICS INC | -- | $19,094.34 | 4,054 | BFDV8K0 |
| 0.02% | RVNC | REVANCE THERAPEUTICS INC | -- | $19,068.91 | 5,761 | BJFSR99 |
| 0.02% | ERAS | ERASCA INC | -- | $18,652.41 | 9,869 | BNLYBF3 |
| 0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $17,865.54 | 9,023 | BLR7H87 |
| 0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $16,223.68 | 3,872 | BMG99Y1 |
| 0.02% | EXAI | EXSCIENTIA PLC | -- | $16,164.63 | 3,151 | BP48134 |
| 0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $15,855.14 | 7,273 | BRK0149 |
| 0.02% | QURE | UNIQURE NV | -- | $15,827.68 | 3,128 | BJFSR88 |
| 0.02% | OVID | OVID THERAPEUTICS INC | -- | $15,328.44 | 4,617 | BYPFK63 |
| 0.01% | BLUE | BLUEBIRD BIO INC | -- | $13,303.31 | 12,433 | BBFL7S1 |
| 0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $12,051.59 | 20,601 | BM9CKX3 |
| 0.01% | RAPT | RAPT THERAPEUTICS INC | -- | $9,530.03 | 2,245 | BK5T6R0 |
| 0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $8,055.32 | 4,426 | BPCK358 |
| 0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,469.30 | 4,635 | BYV2W40 |
| 0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $4,742.78 | 3,566 | BM8MVZ3 |
| -- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,483.20 | 2,177 | BMHR7T5 |
| -- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
| -- | -- | TREASURY BILL | -- | $14,816,722.50 | 15,000,000 | BRYQ9Y9 |
| -- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $13,874,826.47 | 13,874,826 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
2024
- 2024
- 2023
- 2022
| Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
|---|
Portfolio Hedging Series
Part I: The Significance of Portfolio Hedging
Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More